China has unveiled draft regulations on gene-editing and other new biomedical technologies it considers to be "high-risk."
Top Section
Explore Business Standard
Don’t miss the latest developments in business and finance.
China has unveiled draft regulations on gene-editing and other new biomedical technologies it considers to be "high-risk."
First Published: Feb 27 2019 | 9:50 AM IST